You just read:

Stemline Therapeutics, Inc. Announces Presentations of SL-401 Clinical and Pre-Clinical Efficacy at the 52nd Annual Meeting of the American Society of Hematology (ASH)

News provided by

Stemline Therapeutics, Inc.

Dec 01, 2010, 08:30 EST